Skip to content

Stereochemistry Formula Sheet and Short Notes

One-page CSIR NET revision of stereochemistry: CIP rules, stereoisomer counts, conformer energies, A-values, selectivity formulas and asymmetric induction models.

  • 7 min read
  • Updated
On this page · 9 sections
  1. Chirality and stereogenicity
  2. Counting stereoisomers
  3. Axial, planar and helical chirality
  4. Optical activity and topicity
  5. Acyclic conformations
  6. Rings
  7. Selectivity
  8. Asymmetric induction
  9. Where next

Every rule, table and number from Stereogenicity, Chirality and Configurational Isomerism, Conformational Isomerism in Acyclic Systems, Cyclic Systems, Stereospecific and Stereoselective Reactions and Asymmetric Induction, on one page.

Chirality and stereogenicity

  • Chiral ⇔ no improper axis \( S_n \) (σ = \( S_1 \), i = \( S_2 \)). Chiral point groups: \( C_1 \), \( C_n \), \( D_n \), T, O, I.
  • Stereogenic unit: swapping two ligands gives a stereoisomer. Chirality centre: the swap gives the enantiomer. Pseudoasymmetric centre (r/s): stereogenic, achirotopic.
  • Stereogenic units: centre (R/S), double bond (E/Z), axis (Ra/Sa or M/P), plane (Rp/Sp), helix (P/M).
  • Amines invert fast (NH₃ barrier ≈ 24 kJ mol⁻¹); quaternary ammonium, Tröger’s base, phosphines and sulfoxides are configurationally stable.
CIP ruleContent
1higher atomic number at the first point of difference; explore highest branch first
duplicatesC=O → C(O,O); C≡N → C(N,N,N)
2higher mass number (D > H)
3Z > E
4, 5like > unlike; R > S (pseudoasymmetric centres)
  • L-Alanine (S); L-cysteine (R); D-glyceraldehyde (R); L-(+)-lactic acid (S). D/L, R/S and (+)/(−) are independent.
  • –CH₂Br > –CCl₃; –CH₂SH > –COOH; –CH=CH₂ > –CH(CH₃)₂; –C₆H₅ > –C(CH₃)₃.
  • E/Z ≠ trans/cis: trans-2-chlorobut-2-ene (methyls trans) is (Z).
Fischer projectionEffect
180° rotation in planesame compound
90° rotation; one swap; reflectionenantiomer
Lowest group horizontalreverse the traced sense
  • Erythro = same side in Fischer (eclipsed); for adjacent centres this is anti in a zigzag. Prefer syn/anti for zigzag chains.

Counting stereoisomers

CaseTotalMeso
Unsymmetrical, n units\( 2^n \)0
Symmetrical, n even\( 2^{n-1} + 2^{n/2-1} \)\( 2^{n/2-1} \)
Symmetrical, n odd\( 2^{n-1} \)\( 2^{(n-1)/2} \)
  • Tartaric acid 3 (1 meso); trihydroxyglutaric acid 4 (2 meso, C3 r/s); aldaric acids (n = 4) 10 (2 meso).
  • Hepta-2,5-dien-4-ol: 4 stereoisomers, all achiral; C4 pseudoasymmetric only in the (E,Z) isomer.

Axial, planar and helical chirality

ClassChiral when
Allenes / even cumulenesa ≠ b and c ≠ d at the two ends
Odd cumulenes (butatriene)never by the axis: E/Z isomers instead
Biarylshindered rotation, each ring unsymmetrical about the axis
Spiranes, alkylidenecycloalkaneseach end unsymmetrically substituted
(E)-Cyclooctene, paracyclophanes, 1,2-ferrocenesplanar chirality
Hexahelicenehelix P/M
  • Axis naming: near groups outrank far groups; Ra ≡ M, Sa ≡ P.

Optical activity and topicity

  • \( [\alpha] = \alpha/(l\,c) \), l in dm, c in g mL⁻¹.
  • ee ≈ optical purity = \( [\alpha]_{\text{obs}}/[\alpha]_{\text{pure}} \); major fraction = (1 + ee)/2; er = (1 + ee)/(1 − ee).
  • Topicity by substitution: identical → homotopic (\( C_n \)); enantiomers → enantiotopic (σ, i, \( S_n \) only; isochronous in achiral NMR); diastereomers → diastereotopic (anisochronous).
  • Re face: clockwise priority sequence. D⁻ to the Re face of CH₃CHO → (R)-ethanol-1-d; H⁻ to the Re face of CH₃CDO → (S)-ethanol-1-d.

Acyclic conformations

InteractionkJ mol⁻¹
H/H eclipsed≈ 4.0
H/CH₃ eclipsed≈ 6.0
CH₃/CH₃ eclipsed≈ 11
CH₃/CH₃ gauche≈ 3.8
  • Ethane barrier ≈ 12; propane ≈ 14; butane: anti 0 < gauche 3.8 < eclipsed (120°) ≈ 16 < fully eclipsed ≈ 19 kJ mol⁻¹.
  • Butane at 298 K ≈ 70% anti, 30% gauche (degeneracy 2).
  • Klyne–Prelog: sp 0 ± 30°, sc 30–90°, ac 90–150°, ap 150–180°.
  • Gauche preferred: 1,2-difluoroethane (σC–H → σ*C–F); ethylene glycol, 2-fluoroethanol (intramolecular H-bond, non-polar media).
  • 1,2-Dichloroethane: anti in gas; gauche grows with solvent polarity.
  • Propanal: CH₃ eclipses C=O; propene: C–H eclipses C=C; A(1,3) strain fixes allylic conformations; butadiene s-trans > s-cis.
  • Atropisomers (Ōki): \( t_{1/2} \ge 1000 \) s ⇒ ΔG‡ ≈ 92 kJ mol⁻¹ at 300 K.
  • Curtin–Hammett: fast interconversion ⇒ \( P_B/P_A = e^{-(G^\ddagger_B - G^\ddagger_A)/RT} \). Winstein–Holness: \( k_{\text{obs}} = x_Ak_A + x_Bk_B \).

Rings

RingStrain (kJ mol⁻¹)Shape
C₃≈ 115planar, bent bonds
C₄≈ 110puckered
C₅≈ 26envelope / half-chair, pseudorotation
C₆≈ 0chair
Cyclohexane formPoint groupkJ mol⁻¹
Chair\( D_{3d} \)0
Twist-boat\( D_2 \)≈ 23
Boat\( C_{2v} \)≈ 29
Half-chair (TS)\( C_2 \)≈ 45
  • A-values (kJ mol⁻¹, approximate): Me 7.3, Et 7.5, iPr 9.2, tBu ≥ 20, Ph ≈ 12, OH 2.5–4, Cl and Br ≈ 2, CN ≈ 1.

  • \( K = e^{A/RT} \): Me 19:1 (95% equatorial at 298 K).

  • Diequatorial isomers: trans-1,2, cis-1,3, trans-1,4 (each ≈ 7.6 kJ mol⁻¹ more stable for dimethyl).

  • Chirality: trans-1,2 and trans-1,3 chiral; cis-1,2 (flips into its mirror image), cis-1,3, cis- and trans-1,4 achiral. Counts: 1,2 → 3; 1,3 → 3; 1,4 → 2.

  • Anomeric effect: electronegative C2 group of a pyran prefers axial; glucose 36% α : 64% β in water.

  • trans-Decalin: rigid, \( C_{2h} \), ≈ 11 kJ mol⁻¹ more stable than cis; cis-decalin flips.

  • E2 needs trans-diaxial H and leaving group: neomenthyl chloride fast → mainly 3-menthene; menthyl chloride slow → only 2-menthene.

  • 4-tert-Butylcyclohexanone: LiAlH₄/NaBH₄ axial attack → equatorial OH (trans); L-Selectride equatorial attack → axial OH (cis).

  • Axial OH oxidised faster (CrO₃); equatorial OH esterified faster; Fürst–Plattner trans-diaxial epoxide opening.

Selectivity

ereeΔΔG‡ at 298 K (kJ mol⁻¹)
350%2.7
980%5.4
1990%7.3
9998%11.4
19999%13.1
  • \( \Delta\Delta G^\ddagger = RT\ln(\text{er}) \); 5.7 kJ mol⁻¹ per factor of 10; cooling raises er.
  • Stereospecific: stereoisomeric substrates → different stereoisomeric products. Stereoselective: one product preferred. Enantioselective needs a chiral, non-racemic agent. Diastereoselective: simple (aldol, endo) or induced (existing stereocentre).
ReactionCourseZ-2-buteneE-2-butene
Br₂anti(±)meso
OsO₄ / cold KMnO₄synmeso diol(±) diol
mCPBA then H₃O⁺net anti(±) diolmeso diol
Simmons–Smith, singlet carbenesyn, concertedcistrans
Triplet carbenestepwisemixturemixture
  • SN2 inversion; SN1 racemisation (some inversion); SNi retention; NGP net retention; E2 anti; Ei (Cope, Chugaev) syn.
  • Diels–Alder suprafacial, endo kinetic; thermal 4π conrotatory, 6π disrotatory.
  • Z-enolate → syn aldol; E-enolate → anti (Zimmerman–Traxler chair). Lindlar → Z; Na/NH₃ → E. Unstabilised Wittig → Z; stabilised and HWE → E.

Asymmetric induction

ModelRuleProduct
Cram (open-chain)C=O anti to L; attack past SCram product
Felkin–AnhL ⊥ C=O, anti to Nu; Bürgi–Dunitz approach past SFelkin product
Polar Felkin–Anhelectronegative α-group acts as LFelkin product
Chelation (Cram cyclic)small α-OR/NR₂ + Mg, Zn, Ti, Ce; five-membered chelateanti-Felkin
Narasaka–PrasadEt₂BOMe, NaBH₄syn-1,3-diol
Evans–SaksenaMe₄NBH(OAc)₃, intramolecular H⁻anti-1,3-diol
Henbest; VO(acac)₂/TBHPOH-directed epoxidationsyn to OH
MethodKey facts
Evans oxazolidinoneBu₂BOTf/i-Pr₂NEt → Z-boron enolate → Evans syn aldol
Other auxiliariesOppolzer sultam; SAMP/RAMP; pseudoephedrine (Myers); 8-phenylmenthol
ReagentsIpc₂BH (α-pinene); Alpine-Borane; chiral allyl/crotyl boranes
SAETi(OiPr)₄, DET, TBHP; allylic alcohols; L-(+)-DET from the bottom face (standard drawing)
ADAD-mix-α (DHQ)₂PHAL; AD-mix-β (DHQD)₂PHAL
HydrogenationKnowles Rh–DIPAMP (L-DOPA); Noyori Ru–BINAP
OthersCBS (ketones); Jacobsen–Katsuki (unfunctionalised alkenes); proline (aldol); MacMillan (iminium)
  • Double induction: matched ≈ dr(substrate) × dr(reagent); mismatched ≈ dr(reagent)/dr(substrate).
  • Kinetic resolution: \( s = \ln[(1-c)(1-\text{ee}_{SM})]/\ln[(1-c)(1+\text{ee}_{SM})] \); \( c\,\text{ee}_P = (1-c)\,\text{ee}_{SM} \); max 50%. s = 20: c = 50% → both ≈ 79% ee; c = 60% → SM ≈ 98%, P ≈ 65%.
  • DKR and desymmetrisation: up to 100%.
  • Nobel Prizes: 2001 Knowles, Noyori, Sharpless; 2021 List, MacMillan.

Where next

Advertisement
Advertisement